Home Articles

Articles

Articles

Humanizing Healthcare: A Conversation with Summer Knight, MD, MBA

Editorial Team - May 28, 2021

The History, Reality and Promise of Immunotherapy for Cancer

An Evolution to Genomic Testing for DCIS

More Cancer Deaths due to COVID-19-related Delay in Cancer Screening and Reduction in Treatments

Social Needs Linked to Low Health-Related Quality of Life Among African American Cancer Survivors

Improving the Identification of Therapeutic Vulnerabilities in Breast Cancer

Editorial Team - November 18, 2020

Combinability: Addressing Unmet Need in AML

David A. Roth, M.D. - August 20, 2020

Blood test

Detect Cancer Early: Liquid Biopsy Based ctDNA Methylation as a Promising...

Dhruvajyoti Roy, Ph.D. - March 20, 2020

Smoking Cessation as an Integral Part of the Treatment of Patients...

Peter Hofland, Ph.D - February 24, 2020

Featured Image: ELECT-particles on RBCs. This scanning electron microscope (SEM) image shows drug-loaded nanoparticles bound to mouse erythrocytes (red blood cells). Photo Courtesy: Wyss Institute at Harvard University

Drug-loaded Nanoparticles Bound to Circulating Red Blood Cells Inhibit Lung Cancer...

Lindsay Brownell - November 14, 2019

Render of t-cells. Courtesy 2019 Fotolia.

Broadening the Applicability of CAR-T Immunotherapy to Treat the Untreatable

Filippo Petti - October 24, 2019

Nobel Prize in Physiology or Medicine 2019: How do Cells Sense...

Peter Hofland, Ph.D - October 10, 2019

Lung Cancer Among the Most Likely Conditions to Harm Patients who...

Peter Hofland, Ph.D - July 12, 2019

The Signing the National Cancer Act. President Richard Nixon signs the National Cancer Act on December 23, 1971. This is a formal setting with a row of senators visible and some other officials and dignitaries. Courtesy: National Cancer Institute, an agency part of the National Institutes of Health (ID 1935) / Linda Bartlett

Combination Therapy, Combating Cancer from Multiple Flanks

Isaac Israel - July 9, 2019

Three Recommendations to Better Understand HIPAA Compliance

Carol Amick - April 8, 2019

12 3 Page 1 of 3

LATEST NEWS

Regular Blood Monitoring and a Tailored Treatment Approach in Mycosis Fungoides and Sézary Syndrome

Editorial Team - July 22, 2021

The National Cancer Act at 50: The Greatest Scientific Discovery Effort in History.

Peter Hofland, Ph.D - July 21, 2021

In States that Expanded Medicaid Cancer Mortality Rates Declined More Steeply

Editorial Team - July 21, 2021

Breakthrough Therapy Designation for Venetoclax + Azacitidine in Myelodysplastic Syndromes

Editorial Team - July 20, 2021

Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy

Editorial Team - July 18, 2021

Press Releases | Cancer

Local Breast Cancer Patients Experiencing Faster Recovery With PRMA’s... July 23, 2021
PRMA’s ERAS Protocol significantly decreases patient’s postoperative pain after breast reconstruction.(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/local_breast_cancer_patients_experiencing_faster_recovery_with_prmas_new_recovery_protocol/prweb18088964.htm
Mount Sinai Researchers Develop Novel Therapy That Could Be Effective... July 23, 2021
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer...(PRWeb July 23, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_researchers_develop_novel_therapy_that_could_be_effective_in_many_cancers/prweb18083920.htm
Deep Bio Announces Research Collaboration with a Major Cancer... July 22, 2021
Deep Bio renews Research Collaboration Agreement with Dana-Farber Cancer Institute(PRWeb July 22, 2021)Read the full story at https://www.prweb.com/releases/deep_bio_announces_research_collaboration_with_a_major_cancer_institute/prweb18081063.htm